Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| enterocyte | 7 studies | 37% ± 14% | |
| epithelial cell | 6 studies | 27% ± 10% | |
| transit amplifying cell | 3 studies | 23% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| intestine | 3 studies | 28% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 52% | 5310.61 | 504 / 966 | 65% | 28.97 | 344 / 527 |
| bladder | 43% | 802.76 | 9 / 21 | 54% | 23.84 | 274 / 504 |
| skin | 71% | 6443.18 | 1287 / 1809 | 6% | 0.55 | 28 / 472 |
| stomach | 0% | 0 | 0 / 359 | 60% | 25.34 | 171 / 286 |
| prostate | 33% | 320.52 | 82 / 245 | 25% | 1.90 | 125 / 502 |
| uterus | 1% | 7.11 | 2 / 170 | 38% | 11.79 | 176 / 459 |
| esophagus | 0% | 3.59 | 7 / 1445 | 37% | 8.32 | 67 / 183 |
| lung | 2% | 14.33 | 10 / 578 | 29% | 6.74 | 334 / 1155 |
| tonsil | 0% | 0 | 0 / 0 | 27% | 4.87 | 12 / 45 |
| pancreas | 0% | 0 | 0 / 328 | 21% | 8.14 | 38 / 178 |
| ovary | 0% | 0 | 0 / 180 | 17% | 1.48 | 73 / 430 |
| kidney | 15% | 84.75 | 13 / 89 | 1% | 0.05 | 5 / 901 |
| liver | 0% | 0 | 0 / 226 | 5% | 1.69 | 22 / 406 |
| adrenal gland | 0% | 0 | 0 / 258 | 3% | 0.20 | 6 / 230 |
| breast | 0% | 12.69 | 1 / 459 | 2% | 0.49 | 21 / 1118 |
| brain | 1% | 4.51 | 23 / 2642 | 0% | 0.01 | 1 / 705 |
| thymus | 0% | 0 | 0 / 653 | 1% | 0.08 | 6 / 605 |
| adipose | 0% | 3.97 | 3 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 0% | 1.27 | 1 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 1.96 | 1 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0070886 | Biological process | positive regulation of calcineurin-NFAT signaling cascade |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0015031 | Biological process | protein transport |
| GO_0010922 | Biological process | positive regulation of phosphatase activity |
| GO_0042307 | Biological process | positive regulation of protein import into nucleus |
| GO_0032417 | Biological process | positive regulation of sodium:proton antiporter activity |
| GO_0071277 | Biological process | cellular response to calcium ion |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CHP2 |
| Protein name | Calcineurin B homologous protein 2 (Hepatocellular carcinoma-associated antigen 520) |
| Synonyms | HCA520 |
| Description | FUNCTION: Functions as an integral cofactor in cell pH regulation by controlling plasma membrane-type Na(+)/H(+) exchange activity. Binds to and activates SLC9A1/NHE1 in a serum-independent manner, thus increasing pH and protecting cells from serum deprivation-induced death. Also plays a role in the regulation of cell proliferation and tumor growth by increasing the phosphatase activity of PPP3CA in a calcium-dependent manner. Activator of the calcineurin/NFAT signaling pathway. Involved in the cytoplasmic translocation of the transcription factor NFATC3 to the nucleus. . |
| Accessions | ENST00000300113.3 O43745 |